With the new multimillion-dollar conference that kicks off on Tuesday, Indiana is trying to position itself as a globally known innovation hub. And health care will figure prominently on the agenda.
The company, which is developing electrical-nerve stimulation therapies for children, went public this month at an initial price of $6 a share—lower than the range of $7 to $9 a share it announced in February.
The pharmaceutical company has launched 20 drugs in the past decade to treat diseases from arthritis and psoriasis to diabetes and cancer. In recent months, Lilly has overtaken every competitor to become the most valuable drugmaker in the world.
The IU School of Medicine scored a major coup five years ago when it recruited one of the nation’s top experts in the fast-growing field of regenerative medicine. But the University of Pittsburgh recruited him away this spring.
Much of the excitement is due to strong results from Mounjaro, which hit the market in June 2022 as a treatment for Type 2 diabetes and rang up $979.7 million in the quarter.
The Indianapolis-based pharmaceutical company’s first-quarter performance was driven by strong sales of leading drugs for diabetes, cancer and other diseases.
The U.S. Food and Drug Administration gave the green light to MBX to test a drug for post-bariatric hypoglycemia, a rare disease and a serious complication of bariatric surgery, the company said Monday.
Duke Energy Corp.’s $3.5 billion Edwardsport plant was costly to build because of its ability to produce gas from coal. But the plant generated all of its electricity from natural gas in April, May and June.
Walther will provide a one-for-one match for donors who establish endowed children’s cancer research funds at Riley Children’s Foundation, a move that could result in at least $20 million for research of new treatments of children’s cancers.
The acquisition will add about 300,000 members to Indianapolis-based Marathon Health’s network and expand its footprint in 15 states where the two companies do business.
The Federal Trade Commission said CooperCompanies’ decision to abandon the deal “ensures that critical reproductive health markets remain competitive.”
Indiana University Health’s 70,000-square-foot pharmacy hub and distribution center in Plainfield has enough pills, lotions, and infusible and injectable drugs under one roof to supply its 16 hospitals and hundreds of clinics for weeks.
The list includes a hospital executive who collects guitars but can’t play them, and a health insurance leader whose dream job is to become a professional sports coach.
Kristina Lund’s departure means that AES Indiana, formerly known as Indianapolis Power & Light Co., will have gone through five presidents in the past eight years, with some of them lasting less than one year.
The moves will affect employees in Indianapolis, Beech Grove, Lafayette, Michigan City, Dyer, Crown Point and Munster.
It’s turnaround time at Riverview Health, the small, 114-year-old hospital system owned by Hamilton County, which is trying to deal with competition from larger health care systems.
More than 110,000 Hoosiers suffer from Alzheimer’s disease, which robs people of their memories and abilities to do daily tasks, and is the nation’s sixth-leading cause of death.
IU Health expects to give about $690 million worth of work to diversity contractors. That’s 30% of $2.3 billion—the amount the hospital system says the project is worth after subtracting the cost of expensive medical equipment such as imaging scanners.
The move means that patients who need acute hospital care, such as surgery or trauma care, will need to travel more than 20 miles to Jay Hospital in Portland, Ball Memorial Hospital in Muncie or Marion General Hospital in Marion.
David Ricks, CEO of Indianapolis-based drugmaker Eli Lilly and Co., is turning up the volume on his concerns over a new law that would allow Medicare, for the first time, to negotiate drug prices.
